Jiangsu Lianhuan Pharmaceutical Co Ltd Financial Flexibility Index
Jiangsu Lianhuan Pharmaceutical Co Ltd financial flexibility index. Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥19.91 Million (operating CF CN¥-15.07 Million minus capex CN¥34.98 Million) represents 0% of total liabilities (CN¥2.37 Billion). Explore how much does Jiangsu Lianhuan Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Financial flexibility index of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2002 to 2024. Historical Financial Flexibility Index trend for Jiangsu Lianhuan Pharmaceutical Co Ltd across 23 annual periods. Check Jiangsu Lianhuan Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Jiangsu Lianhuan Pharmaceutical Co Ltd Financial Flexibility Index by Year (2002–2024)
Jiangsu Lianhuan Pharmaceutical Co Ltd financial flexibility index by year from 2002 to 2024. Year-by-year free cash flow to debt coverage for Jiangsu Lianhuan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Jiangsu Lianhuan Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.14x | CN¥195.61 Million | CN¥10.77 Million | CN¥1.44 Billion | ▼ -49.8% |
| 2023 | 0.27x | CN¥361.37 Million | CN¥160.70 Million | CN¥1.34 Billion | ▲ +4.4% |
| 2022 | 0.26x | CN¥336.61 Million | CN¥127.59 Million | CN¥1.30 Billion | ▼ -9.6% |
| 2021 | 0.29x | CN¥307.27 Million | CN¥138.34 Million | CN¥1.07 Billion | ▼ -6.8% |
| 2020 | 0.31x | CN¥266.12 Million | CN¥91.94 Million | CN¥867.05 Million | ▲ +55.7% |
| 2019 | 0.20x | CN¥158.76 Million | CN¥-9.87 Million | CN¥805.57 Million | ▲ +156.6% |
| 2018 | 0.08x | CN¥36.36 Million | CN¥-92.00 Million | CN¥473.43 Million | ▼ -57.9% |
| 2017 | 0.18x | CN¥52.28 Million | CN¥3.64 Million | CN¥286.25 Million | ▼ -62.5% |
| 2016 | 0.49x | CN¥116.50 Million | CN¥70.28 Million | CN¥239.03 Million | ▲ +22.8% |
| 2015 | 0.40x | CN¥89.53 Million | CN¥62.12 Million | CN¥225.66 Million | ▼ -4.0% |
| 2014 | 0.41x | CN¥92.87 Million | CN¥69.50 Million | CN¥224.71 Million | ▲ +50.3% |
| 2013 | 0.27x | CN¥68.02 Million | CN¥37.17 Million | CN¥247.36 Million | ▲ +9.8% |
| 2012 | 0.25x | CN¥23.24 Million | CN¥16.94 Million | CN¥92.79 Million | ▼ -47.0% |
| 2011 | 0.47x | CN¥42.98 Million | CN¥24.00 Million | CN¥90.91 Million | ▲ +133.1% |
| 2010 | 0.20x | CN¥18.69 Million | CN¥8.43 Million | CN¥92.13 Million | ▼ -33.1% |
| 2009 | 0.30x | CN¥27.12 Million | CN¥13.83 Million | CN¥89.47 Million | ▼ -50.4% |
| 2008 | 0.61x | CN¥47.69 Million | CN¥17.44 Million | CN¥77.98 Million | ▲ +142.5% |
| 2007 | 0.25x | CN¥22.11 Million | CN¥8.03 Million | CN¥87.69 Million | ▼ -57.4% |
| 2006 | 0.59x | CN¥45.34 Million | CN¥10.14 Million | CN¥76.64 Million | ▲ +77.6% |
| 2005 | 0.33x | CN¥16.47 Million | CN¥3.82 Million | CN¥49.44 Million | ▲ +137.8% |
| 2004 | 0.14x | CN¥8.63 Million | CN¥3.39 Million | CN¥61.63 Million | ▲ +318.4% |
| 2003 | -0.06x | CN¥-3.01 Million | CN¥-13.19 Million | CN¥46.99 Million | ▼ -110.4% |
| 2002 | 0.61x | CN¥25.19 Million | CN¥19.22 Million | CN¥41.02 Million | — |